Stock Analysis

Mentice First Quarter 2025 Earnings: Misses Expectations

OM:MNTC
Source: Shutterstock
Advertisement

Mentice (STO:MNTC) First Quarter 2025 Results

Key Financial Results

  • Revenue: kr54.9m (up 20% from 1Q 2024).
  • Net loss: kr27.5m (loss widened by 12% from 1Q 2024).
  • kr1.08 loss per share (further deteriorated from kr0.96 loss in 1Q 2024).
earnings-and-revenue-growth
OM:MNTC Earnings and Revenue Growth May 12th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Mentice Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 16%. Earnings per share (EPS) also missed analyst estimates by 172%.

Looking ahead, revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Healthcare Services industry in Sweden.

Performance of the Swedish Healthcare Services industry.

The company's shares are down 21% from a week ago.

Risk Analysis

Before you take the next step you should know about the 1 warning sign for Mentice that we have uncovered.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About OM:MNTC

Mentice

Develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology in Europe, the Middle East, Africa, Asia, the Asia Pacific region, and the Americas.

Undervalued with reasonable growth potential.

Advertisement